The reaction of 2-amino-3-cyano-4, 5,6,7-tetrahydrobenzo[b]thiophene with ethyl cyanoacetate gave 2-cyano-N- (3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-acetamide. The latter was used to synthesize different heterocyclic derivatives comprising thiophene, thiazole, pyrazole, pyridine, pyrimidine, and coumarin rings. The mechanistic and synthetic pathways depended on regioselective attack and/or cyclization by the cyanoacetamido moiety in the key precursor on various chemical reagents. The competition of the reaction pathways including dipolar cyclization, dinucleophilic-bielectrophilic attack, β-attack, Gewald-type attack, and condensation reactions led to the diversity of the synthesized products. The antitumor activities of the synthesized products were studied and evaluated. Most of the compounds revealed high inhibitory effects when screened in vitro for their antiproliferative activity. Three human cancer cell lines, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268) were used in the screening tests. The simplicity of the synthetic procedures which mainly involved one-pot reactions under mild reaction conditions, the convenience of yield production and the diversity of the reactive sites in the produced systems play a valuable role for further heterocyclic transformations and further biological investigations.
Introduction
Benzothiophene systems and their substituted derivatives have attracted a great deal of interest over the years. Their aromatic character contributes to their reactivity, stability and chemical and electronic properties. A vast number of heterocyclic derivatives observed in natural products have been reported [1] [2] . On the other side, they find increasing application as superconductors [3] [4] , optoelectronics [5] [6] , light emission diodes LEDs, and non-linear optical (NLO) chromophores [7, 8] . Besides, their pharmacological profiles as antimicrobial [9] [10] , antifungal [11] , antiinflammatory [12] , antiproliferative [13] [14] [15] and antioxidant [16] agents have led to an enduring interest in the development of various methods for their synthesis. The most efficient protocols for carrying out the synthesis of such thiophene derivatives are the Gewald method [17] [18] , intramolecular cyclization via both nucleophilic displacement [14, 19] and thio-Claisen rearrangement [20] , and dehydrophotocyclization [21] [22] . Of particular interest are methods that utilize new classes of precursors. Among the many synthetic methods available are C-C bond formation using Montmorillonite K-10 as Friedel Crafts catalyst [23] . C-C and C-N bond formation via transition metal catalyzed processes involving palladium-mediated cross-coupling cyclizations (e.g., Suzuki, Sonogashira and Buchwald-Hartwig cross coupling), also feature heavily [24] [25] [26] [27] [28] . Within the scope of these diverse synthetic methods and the utility of thiophene-based systems and in continuation to our interest in the design of bioactive heterocycles [29] [30] [31] , we focused our efforts to developing novel highly substituted and polyfunctional heterocyclic compounds based on the key precursor 2-cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]-thiophen-2-yl)-acetamide (2) and evaluating their antitumor activities.
Results and Discussion

Chemistry
The synthetic strategies adopted to obtain the newly synthesized compounds 3-17 depended on the regioselective attack on the cyanoacetamido moiety of the key precursor 2 by different reagents, which, in one or two steps added a highly functionalized substituent or heterocyclic ring to the molecule. The mechanistic pathways for our protocol are outlined in Schemes 1-9. CHNS microanalytical data, IR, , and a characteristic C=O stretching at 1,696 cm (m/z 245) which is also the base peak.
The reactivity of compound 2 towards various chemical reagents was investigated with the aim to producing thiophene systems with potential biological activities. Thus, the reaction of 2 with salicylaldehyde gave the coumarin derivative 4. On the other hand, the reaction of 2 with either benzaldehyde or acetophenone gave the benzylidene derivatives 5 and 6, respectively (Scheme 2). When compound 2 was reacted with acetophenone in the presence of ammonium acetate in an oil bath at 140 °C the Knoevenagel condensation product 6 was obtained (Scheme 2). The structure of compound 6 was based on analytical and spectral data (see Experimental section). Moreover, the GC-MS spectrum of compound 6 revealed a molecular ion peak [M 
Minor products 8a,b were also obtained through the first condensation with the amide C=O followed by cyclization. Microanalysis and spectral data of 7a,b were fully consistent with the proposed structures. The mass spectrum of the pyrazole system 7b exhibited a molecular ion peak [M + ] (m/z 439) corresponding to molecular formula C 25 H 21 N 5 OS. On the other hand, treatment of the benzylidene derivative 4 with methylene carbonitrile reagents (XCH 2 CN; X = CN, X = CO 2 Et) afforded the respective pyridone derivatives 9a,b (Scheme 4). The reaction took place via β-attack on the benzylidene moiety in 4 followed by 1,6-intramolecular dipolar cyclization with concomitant aromatization. The IR spectrum of 9a revealed the presence of three CN stretching bands at  2,253, 2,223 and 2,209 cm −1 . Moreover, the 1 H-NMR spectra of 9a and 9b showed the presence of one singlet for each at δ 3.61 and δ 3.41 ppm, respectively, due to the presence of the NH 2 group. Compound 9b showed a triplet at  1.21 for the ester CH 3 group and a quartet at Further confirmation of the reaction products 9a,b was achieved through an alternative synthetic route involving treatment of the starting compound 2 with benzylidene carbonitrile reagents (PhCH=C(CN)X; X = CN; X = CO 2 Et) to afford the same pyridone derivatives 9a,b (verified by IR fingerprint, m.p. and mixed m.p.) with better yields (80%, 86%) than in their formation by the reaction of compound 4 and either malononitrile (75% yield) or ethyl cyanoacetate (73% yield) (Scheme 4). H-NMR spectrum of compound 11a revealed the existence of two singlets at  3.34 and 3.38 ppm corresponding to two NH 2 groups, while compound 11b showed two singlets at 3.31 and 3.35 ppm corresponding to the two NH 2 groups, a triplet at  1.12 for the ester CH 3 group and a quartet at Next, we moved to the studying of the the reaction of compound 2 with phenyl isothiocyanate in 1,4-dioxane containing triethylamine. The reaction involved a nucleophilic attack by the amidic NH function in 2 on the C=S terminal of the isocyanate reagent to produce the acyclic intermediate A. The latter then underwent 1,6-dipolar cyclization to afford the 6-thioxo-2-pyrimidone derivative 13 as the major product (Scheme 7). Scheme 7. Synthesis of 2-pyrimidone-6-thione 13. On the other hand, we are involved in a comprehensive programme studying the reactivity of active methylene reagents towards phenyl isothiocyanate in basic dimethylformamide followed by heterocyclization with α-halocarbonyl compounds. These reactions lead to the formation of either thiophene or thiazole systems or both, depending on reaction conditions and the nature of the α-halocarbonyl reagent [33] . Thus, subjecting the active methylene key precursor 2 to the aforementioned reaction using α-halocarbonyl reagents XCH 2 C(=O)R (X = Cl, R = OEt; X = Br, R = Ph; X = Cl, R = CH 3 ) afforded the functionalized thiophene and thiazole derivatives 14a,b and 15, respectively (Scheme 8). The reaction took place through the intermediacy of the potassium sulphide salt A. The disappearance of δ- On the other hand, compound 2 reacted with benzenediazonium chloride to give the phenylhydrazo derivative 16. The latter compound reacted with either malononitrile or ethyl cyanoacetate to give the 3-phenylazo-pyridone derivatives 17a and 17b, respectively (Scheme 9). The structural assignments of 16, 17a,b were based on analytical and spectral data. Thus, the 
Biology
In vitro evaluation of antiproliferative activity of the synthesized compounds
The tumor cell growth inhibition activities of the newly synthesized thiophene systems (22 compounds in total) were assessed in vitro [34] on three human tumor cell lines, namely, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer) after a continuous exposure of 48 h. The results were compared to the antiproliferative effects of the reference control doxorubicin [35] . All the compounds were dissolved in DMSO at 1 mg/mL immediately before use and diluted just before addition to the cell culture.
The data (Table 1 ) represents means ± SEM of three independent experiments performed in duplicate. The results indicated that most compounds demonstrated substantial growth inhibitory effects against the human tumor cells at the concentrations tested. The antiproliferative activity of the test compounds against each of the title tumor cell lines may be arranged in a descending order due to measured concentration required to inhibit tumor cell proliferation by 50% (GI 50 µ/M). In general, compounds 17a, 7a, 14b, 4 , and 10a showed significant activity on the three tumor cell lines tested. The inhibitory effect of the other systems on tumor cell growth varied, according to the tested tumor cell, from high to medium or marginal effects. Some compounds had no impact on a specific tumor cell proliferation, while exhibited some specificity to the other. Thus compound 11a revealed GI 50 ~ 66.6 µ/M towards MCF-7 tumor cell versus GI 50 ~ 12.0 µ/M for NCI-H460. Similarly, compound 12 had no effect on NCI-H460 tumor cell proliferation (GI 50 ~ 146 µ/M) while it showed high selectivity towards breast derived cells MCF-7 (GI 50 ~ 10.9 µ/M).
It is of interest that the pyrazole derivative 7a, comprising one phenyl substituent, showed significant growth inhibition activity on the three tumor cell lines, compared to its counterpart 7b with two phenyl functions. Also, comparing the 5-cyano pyridone derivative 17a and its 5-ethoxy-carbonyl counterpart 17b, it is obvious that the former has the highest inhibitory activity towards adenocarcinoma (MCF-7), while 17b showed the lowest effect on the same tumor cell line.
Experimental
General
All melting points were determined on an Electrothermal digital melting point apparatus and are uncorrected. IR spectra (KBr discs) were recorded on a FTIR plus 460 or Pye Unicam SP-1000 spectrophotometer.
1 H-NMR spectra were recorded with Varian Gemini -200 (200 MHz) and Jeol AS 500 MHz instruments in DMSO-d6 as solvent using TMS as internal standard and chemical shifts are expressed as δ ppm. The mass spectra were recorded with Hewlett Packard 5988 A GC/MS system and GCMS-QP 1000 Ex Shimadzu instruments. Analytical data were obtained from the Micro-analytical Data Unit at Cairo University and were performed on Vario EL III Elemental CHNS analyzer.
Chemistry
2-Cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-acetamide (2)
To a solution of 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophene (1) (1.78 g, 0.01 mol) in dimethylformamide (30 mL), ethyl cyanoacetate (1.13 g, 0.01 mol) was added. The reaction mixture was heated under reflux for 5 h. The solid product formed upon pouring onto ice/water mixture was collected by filtration and crystallized from 1,4-dioxane. 
Synthesis of the amide derivatives 4 and 5.
To a solution of 2 (2.45 g, 0.01 mol) in 1,4-dioxane (25 mL) containing piperidine (1.00 mL) either salicylaldehyde (1.22 g, 0.01 mol) or benzaldehyde (1.06 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 5 h. The solid products formed upon pouring onto ice-water mixture containing few drops of hydrochloric acid was collected by filtration and crystallized from 1,4-dioxane. CH aliphatic), 2,216, 2,198 (2CN), 1,692 (C=O), 1,576, 1 To a solution of compound 4 (3.33 g, 0.01 mol) in 1,4-dioxane (25 mL) and dimethylformamide (10 mL), either hydrazine hydrate (0.50 g, 0.01 mol), or phenyl hydrazine (1.08 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 5 h. The solid products formed, in each case, upon pouring onto ice/water mixture containing few drops of hydrochloric acid were collected by filtration, and crystallized from 1,4-dioxane/dimethylformamide mixture. Method (A): To a solution of 4 (3.33 g, 0.01 mol) in 1,4-dioxane (25 mL) and dimethylformamide (5 mL) containing triethylamine (1.00 mL), either malononitrile (0.66 g, 0.01 mol) or ethyl cyanoacetate (1.13 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 5 h, then cooled and neutralized by pouring onto ice/water mixture containing few drops of hydrochloric acid. The solid products formed, in each case, was filtered off and crystallized from 1,4-dioxane/dimethylformamide mixture.
N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-2-oxo-2H-chromen-3-il-carboxamide
2-Cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-phenylacrylamide (5)
.
3-Amino-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-5-phenyl-1H-pyrazol-4-yl-carboxamide (7a
3-Amino-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-1,5-diphenyl-1H-pyrazol-4-yl-carboxamide
Method (B): Equimolar amounts of 2 (2.45 g, 0.01 mol) and either benzylidene malononitrile (1.54 g, 0.01 mol) or benzylidene ethyl cyanoacetate (2.01g, 0.01 mol) in 1,4-dioxane (25 mL) and dimethylformamide (5 mL) containing triethylamine (1.00 mL) were heated under reflux for 5 h. The reaction mixture in each case was treated in a similar manner as in method A. The procedure adopted for the synthesis of 9a,b (Method A) was followed using 2 (2.45 g, 0.01 mol) and either malononitrile (0.66 g, 0.01 mol), ethyl cyanoacetate (1.13 g, 0.01 mol), acetyl acetone (1.00 g, 0.01 mol) or ethyl acetoacetate (1.33 g, 0.01 mol). The solid products formed, in each case, upon treating of the reaction mixtures was crystallized from ethanol/dimethylformamide mixture. Cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-6-hydroxy-4-methyl-1,2-dihydro-2-pyridone-3-carbonitrile (10d) . Pale brown crystals, m.p. 251-255 °C, yield: 2.02 g (65%); Anal. For C 16 To a solution of compound 2 (2.45 g, 0.01 mol) in 1,4-dioxane (25 mL) containing triethylamine (1.00 mL), either malononitrile (0.66 g, 0.01 mol), ethyl cyanoacetate (1.13 g, 0.01 mol) or phenyl isothiocyanate (1.35 g, 0.01 mol) was added followed by the addition of an equimolar amount of elemental sulfur (0.32 g, 0.01 mol). The reaction mixture was heated under reflux for 5 h, then cooled and neutralized by pouring onto ice/water mixture containing few drops of hydrochloric acid. The solid product formed in each case was collected by filtration and crystallized from dimethylformamide. (3-cyano-4,5,6,7- (3-cyano-4,5,6,7- -4,5,6,7-tetrahydrobenzo[b] thiophene-3-carbonitrile (13) . (3-cyano-4,5,6,7- To a solution of 16 (3.49 g, 0.01 mol) in ethanol (25 mL) and dimethylformamide (5 mL) containing triethylamine (1.00 mL), either of malononitrile (0.66 g, 0.01 mol) or ethyl cyanoacetate (1.13 g, 0.01 mol) was added. The reaction mixture, in each case, was heated under reflux for 5 h, then cooled and neutralized by pouring onto ice/water mixture containing few drops of hydrochloric acid. The solid products formed, in each case, was filtered off and crystallized from ethanol/ dimethylformamide mixture. (3-cyano-4,5,6,7- Cell cultures: Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer) were used. MCF-7 was obtained from the European Collection of Cell Cultures (ECACC, Salisbury, UK) and NCI-H460 and SF-268 were kindly provided by the National Cancer Institute (NCI, Cairo, Egypt). They grow as monolayer and routinely maintained in RPMI-1640 medium supplemented with 5% heat inactivated FBS, 2 mM glutamine and antibiotics (penicillin 100 U/mL, streptomycin 100 µg/mL), at 37 o C in a humidified atmosphere containing 5% CO 2 . Exponentially growing cells were obtained by plating 1.5 × 10 5 cells/mL for MCF-7 and SF-268 and 0.75 × 10 4 cells/mL for NCI-H460, followed by 24 h of incubation. The effect of the vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments by exposing untreated control cells to the maximum concentration (0.5%) of DMSO used in each assay.
6-Amino-1-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-2-oxo-4-phenylpyridine-3,5-dicarbonitrile (9a
4-Amino-1-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-6-hydroxy-1,2-dihydro-2-pyridone-3-carbonitrile (10b)
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Conclusions
In summary, we have developed a convenient synthetic approach to 22 novel highly substituted and polyfunctionalized heterocyclic systems based on 2-cyano-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]-thiophen-2-yl)-acetamide. The regioselective attack by different reagents on the cyanoacetamido moiety in the key precursor 2 led to the diversity of the produced systems. All compounds were assessed for their antiproliferative activities on three human cancer cell lines. Most of the systems were found to be promising antiproliferative agents. As a continuation of this work which provides guidance for the development of other new systems based on functionalized 4,5,6,7-tetrahydrobenzo[b]-thiophene core, we intended to study other related systems and the results of further pharmacological investigations will be reported in due course.
